Read More

Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%

Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis industry.

AAWH

Read More

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

ADIL